Absci

Absci is a pioneering biotechnology company that leverages generative artificial intelligence (AI) for drug creation.

Headquarters

Year Founded

Company Status

Website

Sector

Operating Status

Social Media

About Us

Absci is a biotechnology company that uses artificial intelligence to revolutionize the process of creating new biologic drugs. They specialize in designing antibodies from scratch using computer algorithms, bypassing traditional methods that rely on existing antibody libraries. Absci’s platform combines AI-driven design with rapid experimental validation to significantly reduce the time and cost typically associated with bringing new drug candidates to clinical trials.

Latest Articles in AI

CREATORS. DISRUPTORS. INNOVATORS.

Discover Emerging Technology Companies